Published in Am J Physiol on September 01, 1975
Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles. J Physiol (1978) 6.76
Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest (1985) 2.05
Effects of acid-base changes on excitation--contraction coupling in guinea-pig and rabbit cardiac ventricular muscle. J Physiol (1981) 1.24
Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit - the role of buffers. Crit Care (2004) 1.17
Influence of contractile state on the size of the extracellular space in isolated ventricular myocardium. Basic Res Cardiol (1980) 1.00
Enhanced utilization of exogenous glucose improves cardiac function in hypoxic rabbit ventricle without increasing total glycolytic flux. J Clin Invest (1990) 0.89
The electrogenic Na+/HCO3- cotransport modulates resting membrane potential and action potential duration in cat ventricular myocytes. J Physiol (2006) 0.87
The effects of acidosis and bicarbonate on action potential repolarization in canine cardiac Purkinje fibers. J Gen Physiol (1979) 0.84
Interspecies variation in myocardial physiology: the anomalous rat. Environ Health Perspect (1978) 0.82
Some hormonal effects on myocardial phosphate efflux. Biochem J (1984) 0.81
Coronary sinus pH during percutaneous transluminal coronary angioplasty: early development of acidosis during myocardial ischaemia in man. Br Heart J (1987) 0.79
The morphology of Group Ib muscle afferent fibre collaterals [proceedings]. J Physiol (1978) 0.78
Cardiac function and metabolism following hemorrhage in the newborn lamb. Ann Surg (1976) 0.75
Different effects of applied currents during central and peripheral illumination of Pseudemys turtle cones [proceedings]. J Physiol (1978) 0.75
Post-natal ultrastructural development of the cat myocardium [proceedings]. J Physiol (1977) 0.75
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet (1997) 6.48
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet (2000) 5.42
Incidence and aetiology of heart failure; a population-based study. Eur Heart J (1999) 4.56
The epidemiology of heart failure. Eur Heart J (1997) 4.31
Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet (1993) 3.56
Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J (2001) 3.49
Wasting as independent risk factor for mortality in chronic heart failure. Lancet (1997) 3.37
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet (1999) 3.01
Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89
Prevalence of heart failure in three general practices in north west London. Br J Gen Pract (1992) 2.88
Survival of patients with a new diagnosis of heart failure: a population based study. Heart (2000) 2.86
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation (1997) 2.69
Heart failure in a district general hospital. J R Coll Physicians Lond (1992) 2.61
Hospitalization of patients with heart failure: a population-based study. Eur Heart J (2002) 2.54
17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation (1995) 2.49
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation (2000) 2.49
Pathogenesis of edema in constrictive pericarditis. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones before and after pericardiectomy. Circulation (1991) 2.28
Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation (1998) 2.26
Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet (1990) 2.24
Respiratory gas exchange in the assessment of patients with impaired ventricular function. Br Heart J (1985) 2.17
Lanthanum in heart cell culture. Effect on calcium exchange correlated with its localization. J Cell Biol (1972) 2.10
Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) (1986) 2.09
Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol (1997) 2.08
Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol (1997) 2.05
Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation (1993) 2.05
Ion fluxes in cardiac excitation and contraction and their relation to myocardial contractility. Physiol Rev (1968) 2.01
Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J (1990) 2.00
Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J (1998) 1.97
Hypoxia and calcium. J Mol Cell Cardiol (1979) 1.94
The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J (2004) 1.84
Heart: excitation-contraction coupling. Annu Rev Physiol (1973) 1.84
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J (1997) 1.80
Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol (1996) 1.76
Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation (2001) 1.75
Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. Eur Heart J (2004) 1.74
First permanent implant of the Jarvik 2000 Heart. Lancet (2000) 1.68
Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol (1988) 1.66
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol (1997) 1.63
Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol (1993) 1.62
Heart failure: why and how to define it? Eur J Heart Fail (1999) 1.61
Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J (1993) 1.58
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. Eur Heart J (2000) 1.55
Calcium out of control. J Mol Cell Cardiol (1984) 1.55
Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol (1990) 1.53
Effects of strophanthidin upon contraction and ionic exchange in rabbit ventricular myocardium: relation to control of active state. J Mol Cell Cardiol (1970) 1.52
The time of onset and severity of acidosis in myocardial ischaemia. J Mol Cell Cardiol (1980) 1.50
Is aspirin safe for patients with heart failure? Br Heart J (1995) 1.49
Measurement of cardiac output during exercise by the thermodilution and direct Fick techniques in patients with chronic congestive heart failure. Am J Cardiol (1985) 1.46
Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J (1996) 1.46
Predictors of prognosis in severe chronic heart failure. Am Heart J (1992) 1.46
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J (2001) 1.46
Specific uncoupling of excitation and contraction in mammalian cardiac tissue by lanthanum. J Gen Physiol (1970) 1.45
How does the Na(+)-Ca2+ exchanger work in the intact cardiac cell? J Mol Cell Cardiol (1993) 1.44
Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation (1989) 1.44
Testosterone relaxes rabbit coronary arteries and aorta. Circulation (1995) 1.42
Can heart rate variation rule out sleep-disordered breathing in heart failure? Eur Respir J (2006) 1.41
Treatment of chronic heart failure: a review of recent drug trials. Br Med J (Clin Res Ed) (1985) 1.41
Commentary on "Effects of ischaemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium". Cardiovasc Res (2000) 1.41
Non-invasive assessment of vascular function; paradoxical vascular response to intravenous glucose in coronary heart disease. Eur Heart J (2000) 1.39
Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation (1995) 1.39
Sodium-calcium exchange in the heart. Annu Rev Physiol (1982) 1.38
Dimensional accuracy of magnetic resonance in studies of the heart. Lancet (1985) 1.37
Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J (1994) 1.37
Measurement of myocardial intracellular pH in pathological states. J Mol Cell Cardiol (1978) 1.37
Sarcolemmal calcium binding sites in heart: I. Molecular origin in "gas-dissected" sarcolemma. J Membr Biol (1992) 1.36
Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br J Pharmacol (1991) 1.35
The myocardial cell surface, its histochemistry, and the effect of sialic acid and calcium removal on its stucture and cellular ionic exchange. Circ Res (1977) 1.34
Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation (2001) 1.33
Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol (1992) 1.30
Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation (1992) 1.30
Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol (1997) 1.29
The myocardial interstitium: its structure and its role in ionic exchange. J Cell Biol (1974) 1.28
Events at the cardiac sarcolemma: localization and movement of contractile-dependent calcium. Fed Proc (1976) 1.27
Salbutamol in treatment of heart failure. Br Heart J (1980) 1.27
ECS, intracellular pH, and electrolytes of cardiac and skeletal muscle. Am J Physiol (1975) 1.27
Acute effects of diuretics on potassium exchange, mechanical function and the action potential in rabbit myocardium. Clin Sci Mol Med Suppl (1978) 1.25
Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: clinical implications and role of augmented peripheral chemosensitivity. Circulation (1999) 1.25
Effects of acid-base changes on excitation--contraction coupling in guinea-pig and rabbit cardiac ventricular muscle. J Physiol (1981) 1.24
A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community. Eur J Heart Fail (2000) 1.24
Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle. Circulation (1993) 1.24
Effect of 17 beta-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol (1992) 1.22
Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet (1998) 1.22
Contractile responses of isolated adult rat and rabbit cardiac myocytes to isoproterenol and calcium. J Mol Cell Cardiol (1988) 1.22
Haemodynamic effects of salbutamol and nitroprusside after cardiac surgery. Br Heart J (1977) 1.21
The effects of temperature upon contraction and ionic exchange in rabbit ventricular myocardium. Relation to control of active state. J Gen Physiol (1968) 1.21
The subcellular localization of calcium ion in mammalian myocardium. J Cell Biol (1969) 1.21
Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J (1999) 1.20
Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol (1998) 1.19
Myocarditis--a controversial disease. J R Soc Med (1991) 1.19
Hypokalaemia induced by thiazide diuretics in the treatment of hypertension: a cause for concern, not nihilism. Postgrad Med J (1983) 1.19
Calcium concentration and movement in the ventricular cardiac cell during an excitation-contraction cycle. Biophys J (1998) 1.15
Symptoms limiting exercise in chronic heart failure. Br Med J (Clin Res Ed) (1986) 1.14
A comparison of the ventilatory response to carbon dioxide by steady-state and rebreathing methods during metabolic acidosis and alkalosis. Clin Sci Mol Med (1973) 1.14
The effect of beta-adrenoceptor and Ca2+ antagonist drugs on the hypoxia-induced increased in resting tension. Cardiovasc Res (1978) 1.13
Contamination of a cardiac sarcolemmal preparation with endothelial plasma membrane. Biochim Biophys Acta (1986) 1.13
Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J (1990) 1.13
The intrinsic control of myocardial contraction--ionic factors. N Engl J Med (1971) 1.12
Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death. J Hypertens (1992) 1.12